a16z
ALLEYCORP | Groups
OSCAR | BRIDGEWATER
A16Z
ALLEYCORP
Centivo | Oscar
Hint Health | Athenahealth
Akamai
Catalant | Happie
Wachtell Lipton | Teneo
HUDSON RIVER Trading
Bain & Company
Culture with Us
CEDARS-SINAI
Nytilus
NEOHEALTH
Tryon Medical Partners | Aledade
VillageMD | Amazon
ZS
PEGASUS
Recharge | MedBridge
HUMANA
VOLTUS
BRIGHT HEALTH
CENTRAL INTELLIGENCE AGENCY | UNITE US
CLARIFY HEALTH
BONFIRE | DELOITTE
WAYFAIR
CIRCULO HEALTH
PSP Investments | Black Diamond Asset Management
ATHENAHEALTH
CAIN BROTHERS | NYU LANGONE HEALTH
MORECARE | VILLAGEMD
HITAP
WAYFAIR
CAPITAL ONE
AMAZON | VALANT
ENGENDER HEALTH
PHREESIA
ALEDADE
CLOVER | ARCADIA
AMAZON
ThreeFlow | MediaMath
MOUNT SINAI HEALTH PARTNERS
TRIALSPARK | OSCAR
KOMODO HEALTH
WAYFAIR
ATHENAHEALTH
Aetna | Harvard Pilgrim Health Care
ATHENAHEALTH
ALEDADE
EDX | APPLE
ATHENAHEALTH | TIGER CONNECT
PORCH
PRECISIONHEOR
ATHENAHEALTH | POINTCLICKCARE
TALA | CATALANT
VAULT HEALTH | HAVEN HEALTHCARE
ATHENAHEALTH | WAYFAIR
BOSTON CONSULTING GROUP
FLATIRON | OSCAR
HYPERSCIENCE | ZOCDOC
STAYMARQUIS | OSCAR HEALTH
VENDOR | SIMPLY BUSINESS
GORDIAN DATA
AGILECAT
BRIDGEWATER
JPMORGANCHASE | MCGRAW-HILL EDUCATION
STEWARD
ALEDADE
MASSACHUSETTS GENERAL HOSPITAL | DEPARTMENT OF DEFENSE
META
SETTLEMENT HEALTH | MEDICAL SERVICES, INC.
MERCURY | ANGI
LYFT | APPLE
LISTENFIRST MEDIA
SETTLEMENT HEALTH | MEDICAL SERVICES, INC.
BAIN & COMPANY
OSCAR
OSCAR | CLOVER
LURIE CHILDREN’S HOSPITAL
The BRATTLE Group | CATALANT
O’REILLY MEDIA | SEVEN.ME
OSCAR HEALTH
STELLAR HEALTH | CLOVER
EDX
AVANIR PHARMACEUTICALS | ENCOMPASS HEALTH
MERCER
MINDPATH HEALTH
SHIPPINGTREE
AGAPE CARE | MINDPATH HEALTH
VRGL | CARDLYTICS
IMPERFECT FOODS
ATHENAHEALTH | ARCADIA
VERSED | TRUEPILL
INFOSYS
FOUNDATION MEDICINE | THE MEME DESIGN
IBM
Spatially Health
PARETOHEALTH
JPMORGAN CHASE & CO
CATALANT | VISTAPRINT
CARBON HEALTH | KAISER PERMANENTE
KOMODO HEALTH
INVITAE
Mode | Oscar Insurance
NYC DEPARTMENT OF SANITATION (DSNY)
VERAFIN | AMAZON
REDIRECT HEALTH
FIREFLY HEALTH
Oscar Health
ALLEYCORP
ELEMENTAL COGNITION | IBM WATSON
HORIZON BLUE CROSS BLUE SHIELD
Dandelion HEALTH
Tabula Rasa HealthCare | StationMD
FLOATING POINT | OSCAR
OSCAR | BRIDGEWATER
CLOVER | CMS
MCKINSEY & COMPANY
A16Z
KIRKOSWALD | UBS
Vineeta Agarwala, MD, PhD, is a General Partner at Andreessen Horowitz where she leads investments for the firm’s bio fund across therapeutics, diagnostics, and digital health, with a focus on companies that are leveraging unique datasets to improve drug development and patient care delivery. She also serves on the board of BigHat Biosciences.
Prior to joining a16z, Vineeta has held many different roles in the healthcare space: as a physician taking care of patients; as an operator at tech-driven healthcare companies; and most recently as a venture investor on the GV (Google Ventures) life sciences team, focused on biotech companies with a data-driven approach. Previously, she was an early data scientist at Kyruus; a management consultant for biotech, pharmaceutical, and medical device clients at McKinsey & Co; and a Director of Product Management at Flatiron Health, where she led the company’s partnership with Foundation Medicine to integrate real-world clinical and genomic data into national-scale database products to accelerate drug development and research in oncology. She has collaborated with academic researchers at Cold Spring Harbor Laboratory, Lawrence Livermore National Laboratory, and the Broad Institute, where she did graduate work in computational biology and human genetics.
Vineeta holds a B.S. in biophysics from Stanford University, and MD and PhD degrees from Harvard Medical School / MIT. She completed her clinical residency at Stanford, and is board certified in internal medicine. Vineeta continues to see patients at Stanford as an adjunct clinical professor in the Division of Primary Care and Population Health.
Jeffrey De Flavio, MD is co-Founder and Executive Chairman of Pearl Health. He is an Entrepreneur in Residence at AlleyCorp and the Founder of Groups: Recover Together, the national leader in value-based care for treatment of opiate addiction. Dr. De Flavio’s expertise is in value-based care, clinical redesign and building early-stage companies. He received his M.D. from the Dartmouth College of Medicine and his M.B.A. from the Tuck School of Business at Dartmouth.
Michael is co-founder and CEO of Pearl Health. Michael served as an early employee and Vice President at Oscar Health, where he built their sales and network functions. He managed the company’s largest P&L at +$2.5B before helping take the company public with its IPO.
Prior to Oscar, Michael worked for Bridgewater Associates in the company’s Research, Client Service, and Recruiting departments. While at Bridgewater, he was the Head of Research Analytics where he reported to the CEO and Ray Dalio. In 2009 he successfully sold DormAid, a college service company, which he launched and ran while he was a student at Harvard.
He is the recipient of Columbia’s Feldberg Fellowship, where he received his M.B.A. He received his A.B. from Harvard College. In 2024 he was selected as a Presidential Leadership Scholar.
Scott Kupor is an investing partner focused on growth-stage companies building in the bio and healthcare industries, manages the firm’s investor relations team, and is responsible for the firm’s growth initiatives.
Scott was the first employee at Andreessen Horowitz and managed the firm’s growth from $300 million in AUM to more than $30 billion. Prior to joining the firm, Scott worked as vice president and general manager of software-as-a-service at Hewlett Packard. Before that, he held numerous executive management positions at Opsware, including senior vice president of global field operations, vice president of financial planning and vice president of corporate development. Prior to Opsware, Scott represented software companies in both financing and mergers and acquisitions transactions at Credit Suisse First Boston and Lehman Brothers.
Scott is the author of the Wall Street Journal bestselling book, Secrets of Sand Hill Road: Venture Capital and How to Get It, and serves on the boards of Cedar, Headway, Foursquare, Labster, Ultima, and SnapLogic. He also served as chairman of the board for the National Venture Capital Association.
Scott graduated Phi Beta Kappa from Stanford University with a bachelor’s degree in public policy with honors and distinction. He also holds a law degree with distinction from Stanford University and is a member of the State Bar of California.
Kevin Ryan is one of the leading internet entrepreneurs and investors in New York. Alongside AlleyCorp, he co-founded MongoDB, Business Insider, Gilt Groupe, Zola, and Nomad Health, and continues to found new companies with AlleyCorp every year. Collectively, AlleyCorp companies have raised more than $2B in venture capital and employ thousands of people in New York City and beyond. On the investment side, AlleyCorp is one of the most active early stage funds in New York.
Earlier in his career, Kevin helped to grow DoubleClick, first as President and then as CEO, leading their growth from a 20-person startup to a publicly traded global leader with over 1,500 employees, through IPO in 1998 and acquisition by Google in 2007.
Kevin serves on the board of Mercy Corps, is Vice Chairman of The Partnership for New York City, is a member of the CFR Committee on Foreign Affairs, is on the Board of TECH:NYC and is Director Emeritus for Human Right Watch. He previously served on the boards of the Yale Corporation, INSEAD, the Direct Marketing Association, The Ad Council, HotJobs and the advisory board of Doctors Without Borders. He holds a B.A. from Yale University and an M.B.A. from INSEAD.
Gabriel is Chief Operating and Compliance Officer at Pearl Health. He was previously a leader on the Product team at Centivo. While there, he led market launches in New York, New Jersey, Connecticut, Florida and Michigan, in partnership with 14 regional health systems.
Prior to Centivo, Gabriel was an early employee at Oscar Health Insurance, where he served in a number of roles including Director of Product Operations, Chief of Staff, Interim Head of Marketing and in a Special Projects role on the Data Analytics team.
Gabriel received his A.B. in Philosophy from Harvard University. He wrote his honors thesis under the advisement of T.M. Scanlon, in which he argued for an alternative moral framework for justifying informed consent in clinical medicine.
Jennifer Rabiner is Chief Product Officer at Pearl Health. Prior to joining Pearl Health, Jennifer served as a product leader at Hint Health and athenahealth. Her product experience spans value-based care in both the health system and independent provider segments, as well as direct primary care. Jennifer’s experience also includes healthcare revenue cycle process optimization and system implementation at Deloitte Consulting and Triage Consulting Group, as well as pharmaceutical reimbursement strategy and operations at Millennium Pharmaceuticals.
She holds a Master of Healthcare Administration from the University of North Carolina at Chapel Hill, and a B.A. in Social Welfare from the University of California at Berkeley.
Matt is the Chief Technology Officer of Pearl Health. He is a technology industry veteran, with 16 years of startup experience and 7 years at Fortune 1000 public companies. Before joining Pearl, Matt was a Senior Director at Akamai Technologies, where he led global engineering teams for multiple solutions and product lines.
Prior to Akamai, Matt was a founder at SOASTA, which was acquired by Akamai in 2017.
Matt received his Bachelor’s Degree in Computer Science from the University of California, San Diego.
Steven Duque is Chief Growth Officer at Pearl Health. He was previously Vice President of Marketing at Catalant Technologies, where he partnered with cross-functional company leaders to design and execute Catalant’s go-to-market strategy and messaging, build brand awareness through thought leadership and category creation, and enable sales teams and product-led growth to efficiently generate more than 40% year-over-year revenue growth during his tenure. Prior to Catalant, Steven served as Vice President of Product and Marketing at Happie, in addition to serving in various marketing, sales, and evangelism leadership roles at Intuit and Bullhorn, among others.
Steven received his A.B. in Philosophy (primary concentration) and Sociology (secondary field) from Harvard University.
Jonathan E. Goldin serves as Pearl’s General Counsel. He came to Pearl from a global consulting firm, where he was the Chief Operating Officer and General Counsel of its financial advisory business. Before working in-house, Jonathan practiced law at Wachtell, Lipton, Rosen & Katz. He focused on representing corporations, directors and officers in litigation relating to mergers and acquisitions, corporate governance, securities law issues, regulatory inquiries and other complex civil matters. Jonathan began his legal career as a law clerk, first in the U.S. District Court for the Southern District of New York and then in the U.S. Court of Appeals for the Second Circuit.
Jonathan is active in professional organizations, such as the New York City Bar Association and the Association of Corporate Counsel. His public service has included membership on the New York City Water Board (and its Joint Audit Committee with the New York City Water Finance Authority), the Commercial Division Advisory Council of the New York Court System, the New York Chief Judge’s Committee on Non-Lawyers and the Justice Gap and the Pro Bono Advisory Committee of the New York Lawyers for the Public Interest.
Jonathan holds an A.B. from Harvard College, where he was elected to Phi Beta Kappa, and a J.D., magna cum laude, from Harvard Law School.
David is the Chief Financial Officer at Pearl. He is an insurance industry veteran with 27+ years of experience at public and private insurance companies. Most recently, he was CFO at Cowbell Cyber, a privately-held managing general agent selling cyber insurance to small- and medium-sized enterprises in the U.S. and the U.K. Prior to that he was CFO at SiriusPoint, a Bermuda domiciled (re)insurer with operations in the U.S. and Europe listed on the NYSE.
David also spent 20+ years at American International Group in a variety of roles, including CFO, International General Insurance, Treasurer, Head of Capital Management, and CFO, Asia Pacific based in Tokyo. He also worked on mergers & acquisitions and started as a Political Risk Underwriter.
He holds a MBA in Analytical Finance and Accounting from the University of Chicago Booth School of Business, a MAIA in Russian Studies from the Elliott School of International Affairs at The George Washington University, and a BA in International Relations from Boston University.
Dr. Weaver is the Chief Clinical Officer at Pearl. Prior to joining our team, Dr. Weaver was Senior Partner and Value-Based Care Leader at Chartis, a comprehensive healthcare advisory firm, where he helped providers, payers, health systems, and technology companies solve complex care problems and lead new product innovations. Before Chartis, he was Executive Vice President and Chief Clinical Officer at Oscar Health, where he led market expansion and value-based care model innovation with national organizations. He is an experienced board member, currently serving on the Board of Directors of Ruby Health, a technology focused value based care enablement platform for home health and post acute care organizations.
Dr. Weaver received his MD from the University of Iowa, after attending the United States Air Force Academy. He is a board-certified obstetrician gynecologist, and served as a physician in various clinical and leadership roles in Air Force and Department of Defense health centers. He received his MBA from Washington University in St. Louis.
Dr. Berg is Pearl’s Executive Vice President of Clinical Strategy. Cameron received his BA from Pomona College, his MD with honors from The George Washington University School of Medicine, and then completed specialty training in Emergency Medicine at Stanford. He worked as an emergency physician while developing an interest in population health, and cultivated a passion for disambiguating complicated workflows.
Cameron suffered major injuries in 2020, when he was hit by a car while bicycling to work; the resulting traumatic brain injury prevented him from returning to clinical work, and his personal experiences with healthcare reinforced his commitment to physician/patient-centered care.
Patrick Mauro is a data scientist enabling Pearl Health’s mission by creating a quantitative framework around the complex problem of efficiently delivering high-quality healthcare.
Patrick learned the craft of statistical analysis and distributed computing while working as a high-frequency trader at Hudson River Trading, where he led a team trading US and European equities. Thereafter, Patrick has consulted in a variety of industries, from entertainment to food rescue to biomedical engineering. He is passionate about performing sophisticated analyses of complex data sets in order to deliver actionable business insights and architect advanced computing systems. When not combing over data, Patrick also works as a mountain guide, where he delves into a far less quantitative but far more tangible world of risk analysis.
Patrick holds a S.M. in Electrical Engineering and an A.B. in Electrical Engineering and Computer Science from Harvard College.
Ciara is the Chief of Staff at Pearl Health. She previously worked as a Consultant at Bain & Company in London, where she advised businesses on M&A due diligence, strategy, separation and integration, cost reduction, and marketing. While at Bain, Ciara also led / worked on a number of pro-bono strategy projects with social enterprises and charities across Kenya, India, and the UK.
Following this, Ciara worked as an Investment Associate for an Irish impact investing fund, VentureWave, and she co-founded a climate-tech start-up.
Ciara has an MBA from Harvard Business School and a BA in Management Science and Information Systems from Trinity College Dublin.
Joe is the Executive Vice President, Finance and Strategy at Pearl Health. Prior to joining Pearl, Joe had been a portfolio manager for the Public Sector Pension Investment Board of Canada, before co-founding Black Diamond Asset Management, a mutual and hedge fund manager. Joe continues to serve as an advisor of Black Diamond and as a director of Metafix Inc., an engineering firm in the industrial wastewater sector, where he had previously been Chief Financial Officer.
Joe serves on the board of Tomorrow’s Voices, an autism early intervention center located in Bermuda, as well as on committees and boards of various alumni and public-benefits oriented organizations.
Joe has an A.B. in Economics & Mathematics, cum laude, with Joint-High Honors, from Harvard College, as well as an MSc in Financial Economics with Distinction from the Saïd Business School, University of Oxford, where he was elected president of his class.
